At PHARMAPACK in Paris, Spang & Brands is going to spotlight two innovative pharmaceutical devices: A single-use nasal dosing device and a sterile connector. With the special single-use dosing device, Spang & Brands is setting a new standard in medication of nasal mucosa. The sterile connector is especially designed to transport liquids such as infusion solutions, medications or stored blood regardless of the degree of sterility of the environment. Besides those two highlights, the company will exhibit two-part sealing systems made of TPE and various caps for pharmaceutical primary packaging such as glass bottles and bottle packs as well as mixing and dosing systems.
 |
|
Single-use nasal dosing device |
The first highlighted product is the single-use nasal dosing device, enabling highly precise application of the drug to the nasal mucosa. In general, there is a growing trend to administer medications via mucosa because it enables direct application of minimal doses and many patients are afraid of needles. The dosing device is designed to be patient friendly and ensures precise agitating of the medication and obtains the expected fast, and strong effect. The patented dosing system has a simple structure consisting of four plastic parts and can be used as platform for custom developments.
Sterile connectors will be highlighted, too. Solutions (liquid medications, pharmaceuticals or stored blood) can be transported safely through the sterile connector from bags, bottles or ampoules to another container and finally transfused into the patient with no risk of contamination. Jurgen Mader, Chief Technology Officer, pointed out the advantages of the new system: “Regardless of the environmental conditions, there is no risk of contamination thanks to the sterile, particle-free connection”. Mader added a few striking examples: “If need be, the connection can be set up outside the hospital, outdoors, or at the patient's home“. Since pathogens typical of hospitals can crop up anywhere, sterile connectors mean one less thing to worry about. The sterile connector is safe and easy to handle. Friedrich Echterdiek, Chairman of the Management Board, expressed his confidence: “This patented technology has potential for a wide variety of future applications”.
 |
|
Sterile connector |
Spang & Brands will also exhibit a sterile bag-sealing system consisting of a 2-component plastic TPC (temper proof cap). The company will also exhibit 2-port bottle pack caps with TPE sealing components, break-off caps made of various plastic parts and combinations of materials, and other sealing systems.
Along with its brand-name products, Spang & Brands operates as an expert supplier under contract for customer projects involving ready-to-use pharmaceutical and medical packaging.
Spang & Brands handles every step in new customer projects: from the idea to the finished product. Its in-house technology centre ensures the seamless flow of CAD tool data and very-high-precision CAM tooling for pharmaceutical technical products: “Precise to within a micron“, said Alexander Marz, Chief Technology Officer. At PHARMAPACK, the company will exhibit a variety of pharmaceutical and medical technology systems: injection-moulded single- and multi-component high-precision and micro products, such as connecting pieces, working parts for infusion solution bags and sealing systems, penetrable membranes, catheters, syringes, implant components for minimally invasive treatment, as well as assembled components. “We have been specializing in precision and clean-room injection moulding technology for the medical and pharmaceutical industry for over 35 years. We have both the latest equipment and a highly skilled and experienced team”, explained Echterdiek. Clean rooms are used for fully automated and manual assembly and packing of the parts and assemblies – from pilot lots or just-in-time lots ranging from small series to mass production in the millions. Quality control is supported by strategically positioned test points and 3D measurement technology.
The CEO affirms that: “Pharmaceutical primary packaging is becoming increasingly demanding in terms of ease of use and optimal safety for the patient. At PHARMA-PACK, we are going to demonstrate that we have mastered the technology neces-sary to that purpose: parts development, mould making, injection-moulding technology – 70 machines, mainly electrical, clean room applications, assembly and production processes for the entire value chain.”
At the exposition, Mr Echterdiek, Mr Mader and Marz will be happy to answer any questions clients may have.
